论文部分内容阅读
在对可疑或已确诊的妇科恶性肿瘤患者进行剖腹探查时,腹膜细胞学(PC)检查已公认为评价患者的方法之一,并于1975年国际妇产科协会(FIGO)结合PC制订了卵巢癌的分期。但有关PC在子宫内膜癌中的预后价值,结论尚不一致。1961年,Morton等首先报道了16例宫体癌患者中4例腹腔冲洗液发现癌细胞。但直到1981年才开始对子宫内膜癌患者的PC进行研究,本文对此种检查的重要性及其在早期子宫内膜癌病人处理中的作用作一评价性综述。一、细胞学技术
Peritoneal cytology (PC) has been recognized as one of the methods of evaluating patients for exploratory laparotomy in patients with suspected or confirmed gynecological malignancies and has developed ovaries in association with PC in 1975 by the International Association of Obstetrics and Gynecology (FIGO) Cancer staging. However, the prognosis of PC in the prognosis of endometrial cancer, the conclusion is not consistent. In 1961, Morton et al. First reported the discovery of cancer cells in 4 cases of peritoneal wash in 16 patients with uterine cancer. However, it was not until 1981 that the study of PC in patients with endometrial cancer began. The importance of this test and its role in the treatment of patients with early endometrial cancer were reviewed. First, cytological techniques